463 related articles for article (PubMed ID: 22489356)
21. [Marginal zone lymphomas: extranodal MALT type, nodal and splenic].
Dallenbach FE; Coupland SE; Stein H
Pathologe; 2000 Mar; 21(2):162-77. PubMed ID: 10840821
[TBL] [Abstract][Full Text] [Related]
22. Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.
Matutes E; Oscier D; Montalban C; Berger F; Callet-Bauchu E; Dogan A; Felman P; Franco V; Iannitto E; Mollejo M; Papadaki T; Remstein ED; Salar A; Solé F; Stamatopoulos K; Thieblemont C; Traverse-Glehen A; Wotherspoon A; Coiffier B; Piris MA
Leukemia; 2008 Mar; 22(3):487-95. PubMed ID: 18094718
[TBL] [Abstract][Full Text] [Related]
23. Nodal marginal zone lymphoma.
Angelopoulou MK; Kalpadakis C; Pangalis GA; Kyrtsonis MC; Vassilakopoulos TP
Leuk Lymphoma; 2014 Jun; 55(6):1240-50. PubMed ID: 24004184
[TBL] [Abstract][Full Text] [Related]
24. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
25. Early-stage splenic diffuse large B-cell lymphoma is highly associated with hepatitis C virus infection.
Yu SC; Lin CW
Kaohsiung J Med Sci; 2013 Mar; 29(3):150-6. PubMed ID: 23465418
[TBL] [Abstract][Full Text] [Related]
26. [Splenic lymphoma, diagnosis and treatment].
Riller Q; Cohen-Aubart F; Roos-Weil D
Rev Med Interne; 2022 Oct; 43(10):608-616. PubMed ID: 35691756
[TBL] [Abstract][Full Text] [Related]
27. Marginal zone-related neoplasms of splenic and nodal origin.
Arcaini L; Paulli M; Boveri E; Magrini U; Lazzarino M
Haematologica; 2003 Jan; 88(1):80-93. PubMed ID: 12551831
[TBL] [Abstract][Full Text] [Related]
28. Marginal zone B-cell lymphomas including mucosa-associated lymphoid tissue type lymphoma (MALT), monocytoid B-cell lymphoma and splenic marginal zone cell lymphoma and their relation to the reactive marginal zone.
de Wolf-Peeters C; Pittaluga S; Dierlamm J; Wlodarska I; Van Den Berghe H
Leuk Lymphoma; 1997 Aug; 26(5-6):467-78. PubMed ID: 9389354
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus infection and locally advanced splenic marginal zone lymphoma.
Szynglarewicz B; Matkowski R; Smorag Z; Forgacz J; Pudelko M; Kornafel J
Pathol Oncol Res; 2007; 13(4):382-4. PubMed ID: 18158578
[TBL] [Abstract][Full Text] [Related]
30. Marginal-zone lymphoma.
Ferreri AJ; Zucca E
Crit Rev Oncol Hematol; 2007 Sep; 63(3):245-56. PubMed ID: 17583528
[TBL] [Abstract][Full Text] [Related]
31. Splenic and nodal marginal zone lymphomas are indolent disorders at high hepatitis C virus seroprevalence with distinct presenting features but similar morphologic and phenotypic profiles.
Arcaini L; Paulli M; Boveri E; Vallisa D; Bernuzzi P; Orlandi E; Incardona P; Brusamolino E; Passamonti F; Burcheri S; Schena C; Pascutto C; Cavanna L; Magrini U; Lazzarino M
Cancer; 2004 Jan; 100(1):107-15. PubMed ID: 14692030
[TBL] [Abstract][Full Text] [Related]
32. Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma.
Munari E; Rinaldi M; Ambrosetti A; Bonifacio M; Bonalumi A; Chilosi M; Zamò A
Virchows Arch; 2012 Dec; 461(6):677-85. PubMed ID: 23064660
[TBL] [Abstract][Full Text] [Related]
33. [Clinicopathologic study of splenic marginal zone B-cell lymphoma].
Zhang YN; Zheng YY; Zhou XG; Zhang SH; Jin Y; Xie JL; Chen SY; Shi Y; Wu LH
Zhonghua Bing Li Xue Za Zhi; 2009 Apr; 38(4):243-7. PubMed ID: 19575895
[TBL] [Abstract][Full Text] [Related]
34. Splenic B-cell lymphomas with more than 55% prolymphocytes in blood: evidence for prolymphocytoid transformation.
Hoehn D; Miranda RN; Kanagal-Shamanna R; Lin P; Medeiros LJ
Hum Pathol; 2012 Nov; 43(11):1828-38. PubMed ID: 22520947
[TBL] [Abstract][Full Text] [Related]
35. Comparative study of marginal zone lymphoma involving bone marrow.
Kent SA; Variakojis D; Peterson LC
Am J Clin Pathol; 2002 May; 117(5):698-708. PubMed ID: 12090417
[TBL] [Abstract][Full Text] [Related]
36. Clinical Characteristics, Treatment and Evolution of Splenic and Nodal Marginal Zone Lymphomas-Retrospective and Multicentric Analysis of Portuguese Centers.
Rodrigues CD; Peixeiro RP; Viegas D; Chorão P; Couto ME; Gaspar CL; Fernandes JP; Alves D; Ribeiro LA; de Vasconcelos M P; Tomé AL; Badior M; Coelho H; Príncipe F; Chacim S; da Silva MG; Coutinho R
Clin Lymphoma Myeloma Leuk; 2021 Nov; 21(11):e839-e844. PubMed ID: 34326035
[TBL] [Abstract][Full Text] [Related]
37. Lupus anticoagulant and thrombosis in splenic marginal zone lymphoma.
Gebhart J; Lechner K; Skrabs C; Sliwa T; Müldür E; Ludwig H; Nösslinger T; Vanura K; Stamatopoulos K; Simonitsch-Klupp I; Chott A; Quehenberger P; Mitterbauer-Hohendanner G; Pabinger I; Jäger U; Geissler K
Thromb Res; 2014 Nov; 134(5):980-4. PubMed ID: 25201005
[TBL] [Abstract][Full Text] [Related]
38. Splenic marginal zone lymphoma: disease features and management.
Matutes E
Expert Rev Hematol; 2013 Dec; 6(6):735-45. PubMed ID: 24168526
[TBL] [Abstract][Full Text] [Related]
39. Results of Upfront Therapy for Marginal Zone Lymphoma.
Ortega JL; Cabanillas F; Rivera N; Tirado-Gomez M; Hallman D; Pardo WI; Bruno M
Clin Lymphoma Myeloma Leuk; 2017 Dec; 17(12):879-883. PubMed ID: 29042174
[TBL] [Abstract][Full Text] [Related]
40. MYD88 (L265P) somatic mutation in marginal zone B-cell lymphoma.
Martinez-Lopez A; Curiel-Olmo S; Mollejo M; Cereceda L; Martinez N; Montes-Moreno S; Almaraz C; Revert JB; Piris MA
Am J Surg Pathol; 2015 May; 39(5):644-51. PubMed ID: 25723115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]